Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W. Tenforde, Wesley H. Self, Katherine Adams, et al.
JAMA (2021) Vol. 326, Iss. 20, pp. 2043-2043
Open Access | Times Cited: 586

Showing 1-25 of 586 citing articles:

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Qian Wang, Sho Iketani, Zhiteng Li, et al.
Cell (2022) Vol. 186, Iss. 2, pp. 279-286.e8
Open Access | Times Cited: 743
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Adam S. Lauring, Mark W. Tenforde, James D. Chappell, et al.
BMJ (2022), pp. e069761-e069761
Open Access | Times Cited: 581
BNT162b2 Protection against the Omicron Variant in Children and Adolescents
Ashley M. Price, Samantha M. Olson, Margaret M. Newhams, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 20, pp. 1899-1909
Open Access | Times Cited: 221
SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
Paddy Ssentongo, Anna E. Ssentongo, Navya Voleti, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 219
Winter of Omicron—The Evolving COVID-19 Pandemic
Carlos del Rı́o, Saad B. Omer, Preeti Malani
JAMA (2021) Vol. 327, Iss. 4, pp. 319-319
Open Access | Times Cited: 210
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Venice Servellita, Abdullah M. Syed, Mary Kate Morris, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1539-1548.e5
Open Access | Times Cited: 159
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Mark W. Tenforde, Wesley H. Self, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 12, pp. 459-465
Open Access | Times Cited: 159
COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022
Fiona P. Havers, Huong Pham, Christopher A. Taylor, et al.
JAMA Internal Medicine (2022) Vol. 182, Iss. 10, pp. 1071-1071
Open Access | Times Cited: 149
Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis
Ryan Ruiyang Ling, Kollengode Ramanathan, Felicia Liying Tan, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 7, pp. 679-688
Open Access | Times Cited: 139
Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
Shuai Xia, Lijue Wang, Yun Zhu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 134
Oral Nirmatrelvir and Ritonavir in Nonhospitalized Vaccinated Patients With Coronavirus Disease 2019
Sarju Ganatra, Sourbha S. Dani, Javaria Ahmad, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 4, pp. 563-572
Open Access | Times Cited: 130
COVID-19 2022 update: transition of the pandemic to the endemic phase
Michela Biancolella, Vito Luigi Colona, Ruty Mehrian‐Shai, et al.
Human Genomics (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 118
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
Katherine Adams, Jillian P. Rhoads, Diya Surie, et al.
BMJ (2022), pp. e072065-e072065
Open Access | Times Cited: 92
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults — United States, August–December 2021
Mark W. Tenforde, Manish M. Patel, Manjusha Gaglani, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 4, pp. 118-124
Open Access | Times Cited: 91
Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
William Wang, David C. Kaelber, Rong Xu, et al.
JAMA Oncology (2022) Vol. 8, Iss. 7, pp. 1027-1027
Open Access | Times Cited: 84
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns
Joseph Cabore, Humphrey Karamagi, Hillary Kipruto, et al.
The Lancet Global Health (2022) Vol. 10, Iss. 8, pp. e1099-e1114
Open Access | Times Cited: 83
IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
Vladimir N. Uversky, Elrashdy M. Redwan, William Makis, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 991-991
Open Access | Times Cited: 78
Waning COVID-19 Vaccine Effectiveness for BNT162b2 and CoronaVac in Malaysia: An Observational Study
Jing Lian Suah, Masliyana Husin, Peter Seah Keng Tok, et al.
International Journal of Infectious Diseases (2022) Vol. 119, pp. 69-76
Open Access | Times Cited: 67
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods
Ruth Link‐Gelles, Matthew E. Levy, Karthik Natarajan, et al.
JAMA Network Open (2023) Vol. 6, Iss. 3, pp. e232598-e232598
Open Access | Times Cited: 65
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
mRNA vaccines against SARS-CoV-2 induce comparably low long-term IgG Fc galactosylation and sialylation levels but increasing long-term IgG4 responses compared to an adenovirus-based vaccine
Jana Sophia Buhre, Tamás Pongrácz, Inga Künsting, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 63
Role of T cells in severe COVID-19 disease, protection, and long term immunity
Julia Maret Hermens, Can Keşmir
Immunogenetics (2023) Vol. 75, Iss. 3, pp. 295-307
Open Access | Times Cited: 42
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
Alexandre R. Marra, Takaaki Kobayashi, Gustavo Yano Callado, et al.
Antimicrobial Stewardship & Healthcare Epidemiology (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 40
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis
Zoe Raglow, Diya Surie, James D. Chappell, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e235-e246
Open Access | Times Cited: 35
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults
Diya Surie, Katharine A. Yuengling, Jennifer DeCuir, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e244954-e244954
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top